Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1153 (LINC01153)
- Target
- LINC01153
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA) family member
01
Overview
Long intergenic non-protein coding RNA 1153 (LINC01153) is a member of the long intergenic non-coding RNA (lincRNA) family, comprising autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap any annotated protein-coding genes. LincRNAs, including LINC01153, are involved in fine-tuning the expression of neighboring genes, remodeling chromatin, stabilizing RNA, and transcriptional regulation, often with tissue specificity. Most lincRNAs—including LINC01153—are not well-characterized at the molecular or functional level. As a non-coding RNA, LINC01153 is not conventionally viewed as a direct drug target, and no current evidence indicates its involvement in disease or efficacy as a biomarker. Research on lincRNAs is ongoing to elucidate their specific biological functions, regulatory roles, and potential associations with diseases.
- Other names
- LINC01153
02
Mechanism of action
Not applicable; there are no drugs known to specifically target LINC01153, and lincRNAs typically exert regulatory roles via non-protein/RNA-mediated processes
03
Biological functions
Chromatin and genome architecture regulationRNA stabilizationTranscriptional regulationPotential enhancer-associated activity (typical of some lincRNAs)
04
Safety considerations
None noted; lincRNAs pose general challenges for therapeutic development such as off-target effects and delivery for RNA-based interventions, but nothing specific to LINC01153
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1153 (LINC01153).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1153 (LINC01153).